BiomX Inc. (PHGE) Earnings Call Transcript & Summary

June 26, 2026

NYSEAM US Health Care Biotechnology shareholder_meeting

Earnings Call Speaker Segments

Michael Oster

executive
#1

Good morning, everyone, and welcome. I'm Michael Oster, Chief Executive Officer of BioMax. It's 9:00, so let me call the 2026 Annual Meeting of Stockholders of BiomexInc, to order. Thank you all for being here. I'll be chairing the meeting this morning. We're holding this year's meeting entirely online by live webcast the way we described in the proxy materials. Let me introduce the people joining me. With me today are David Rokach, our Chief Financial Officer; and David Audi and Josh Ettinger of A but Legal Group, the company's outside counsel, a representative of Continental Stock Transfer and Trust Company, our transfer agent, is here as well, serving as our inspector of elections. We gave notice of this meeting and made the proxy materials available to stockholders the way our bylaws and the law require. The Board set the close of business of June 2, 2026 as the record date. If you held shares as of that date, you are entitled to vote today. As of the record date, the company had 11,160,153 shares of common stock outstanding and entitled to vote. Proof that we gave notice will be kept with the records of the meeting. Under our bylaws, we have a quorum as long as stockholders holding at least 1/3 of the shares entitled to vote are represented either here or webcast or by proxy. The Inspector of Elections has confirmed that we have a quorum, so the meeting is properly convened and we can turn to our business. We have 3 items to vote on today, and each 1 is described in the proxy statement. If you've already voted by proxy, there is nothing more you need to do. Your shares will be voted exactly as you instructed. And if you're a stockholder of record attending today and you haven't voted yet, you can still vote through the meeting website. The polls are now open. Here are the 3 proposal. First is the election of Ran Shaked as our sole Class II director to serve until 2029 Annual Meeting and until his successor is elected and qualified. The Board recommends that you vote for Mr. Shaker. Second is an amendment to our 2026 equity incentive plan. It would increase the number of shares available under the plan by 5,460,000, bringing the total to 5,685,000. The Board recommends that you vote for this proposal. Third is an adjournment proposal, it would let us adjourn this meeting to gather more votes if we don't have enough to approve the first 2 items. The Board recommends the vote for it as well. You will find the full details of each 1 in the proxy statement. We won't be taking questions live during the meeting. If you'd like to submit a question, you can do so through the webcast and the company will respond to the questions of general interest after the meeting. The polls are now closed. We can't accept any more votes. Let me give you the preliminary results based on the Inspector of Elections report. Here's the preliminary count. Mr. Shaked received the votes needed and is elected as our Class III Director. The amendment to the 2026 equity incentive plan received the votes needed and is approved because the first 2 proposals passed, we don't need to adjourn and we will. These numbers are preliminary. The inspector of elections will certify the final results, and we'll report them in a Form 8-K that we'll file with the SEC. There's no further business before the meeting, so I declare the 2026 Annual Meeting of Stockholders adjourned. On behalf of the Board of directors and management team, thank you all for your interest in BioMex and for your support. That concludes our meeting.

For developers and AI pipelines

Programmatic access to BiomX Inc. earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.